Kedrion Biopharma
Massimo Rossi is an experienced IT security and infrastructure professional with a strong background in managing complex network architectures and cybersecurity strategies. Currently serving as the IT Security Manager at Kedrion Biopharma since August 2021, Massimo is responsible for developing the Information and Cyber Security Strategy, overseeing governance initiatives, conducting risk assessments, and leading the Cyber Incident Response Team. Prior to this role, Massimo held positions as IT Infrastructure Architect at Sysdat International SA and SYSDAT.IT, where responsibilities included designing and managing enterprise-level network systems, security architectures, and virtualization infrastructures. Earlier career experiences include roles as a Datacenter Administrator at Lucense SCpA and internships focused on security management and network analysis. Massimo holds a degree in Computer Science from Università di Pisa.
Kedrion Biopharma
19 followers
Kedrion Biopharma is a biopharmaceutical company that collects and fractionates blood plasma to produce and distribute worldwide plasma-derived therapies for use in treating and preventing rare and serious diseases and conditions. In 2022, Kedrion joined forces with BPL (Bio Products Laboratory). Based in the United Kingdom, BPL has over 60 years of experience in the supply of high-quality plasma-derived medicines to treat rare diseases. Kedrion distributes its products in over 100 countries around the world. We have plants in Italy, Hungary, UK and North America, and plasma collection centers in the US and in the Czech Republic. With these figures we are the world’s 5th top player in the field of plasma-derived products. Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.